权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Patient and Provider perspectives on long acting injectable ART

患者和医疗服务提供者对长效注射 ART 的看法

基本信息

批准号：
10589878
负责人：
CLARE L BARRINGTON
金额：
$ 50.16万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-05-15 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10589878
关键词：
Acquired Immunodeficiency Syndrome Adherence Adverse effects Caring Characteristics Clinic Clinical Clinical Research Communication Data Decision Making Development Disadvantaged Disclosure Dose Drug resistance Enrollment Ensure Face Fatigue Feeling Formulation Fostering Frequencies Geography Goals HIV HIV Infections HIV therapy Health Personnel Home Individual Injectable Injection Site Reaction Injections Insurance Interview Intramuscular Intramuscular Injections Investigation Medical Mental Health Oral Participant Patient Preferences Patient Selection Patients Perception Persons Pharmaceutical Preparations Phase Procedures Process Provider Quality of life Recording of previous events Regimen Reporting Research Research Design Research Methodology Resistance Respondent Risk Rural Sampling Scientist Site Stigmatization Structure Surveys System Tablets Testing Therapeutic Therapy trial Trust Viral Work antiretroviral therapy care providers clinical care clinical center cohort comorbidity demographics design drug development experience gastrointestinal individual patient informant innovation insight interest men who have sex with men pill preference prevent recruit research study residence shared decision making social social stigma substance use tool tool development uptake

项目摘要

ABSTRACT Long-acting injectable antiretroviral therapy (LAI ART) is anticipated to be a major advance in the management of HIV infection. However, how this therapeutic innovation will be received among patients and providers remains unclear. At present, there are few data with which to forecast, let alone, plan for incorporation of this innovation in HIV care into practice. Our preliminary studies demonstrate excitement for LAI ART among participants in research trials of this mode of ART administration, with possibly less enthusiasm among HIV care providers. With the proposed research studies, we seek to gain a deeper understanding of the perceptions regarding LAI ART among diverse groups of PLHIV in the US and their care providers. This understanding will be used to inform the roll-out of LAI ART, including the development of tools that PLHIV and providers can use to guide shared decision-making when choosing among treatment options.

摘要长效注射抗逆转录病毒疗法(LAI ART)有望成为艾滋病毒感染的管理。然而，这一治疗创新将如何在患者和供应商仍不清楚。目前，几乎没有数据可以用来预测，更不用说计划合并了将艾滋病毒护理的这一创新付诸实践。我们的初步研究显示，人们对赖艺术感到兴奋参与这种抗逆转录病毒药物管理模式的研究试验的参与者，在艾滋病毒护理中可能热情较低供应商。通过建议的研究研究，我们寻求对这些认知的更深入的理解关于LAI ART在美国不同的PLHIV群体及其护理提供者中的应用。这一理解将用于通知LAI抗逆转录病毒疗法的推出，包括开发艾滋病毒/艾滋病和艾滋病提供者可使用的工具以指导在选择治疗方案时的共享决策。